Does age really matter? Radiotherapy in elderly patients with glioblastoma, the Munich experience

BACKGROUND: Glioblastoma is usually diagnosed around the age of 60–70 years. Patients older than 65 years are frequently described as “elderly”. Several trials with monotherapy have established treatment regimens that offer therapies with reduced side effects but reduced efficacy. We analysed the ou...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Radiat Oncol
Autori principali: Straube, Christoph, Scherb, Hagen, Gempt, Jens, Bette, Stefanie, Zimmer, Claus, Schmidt-Graf, Friederike, Schlegel, Jürgen, Meyer, Bernhard, Combs, Stephanie E.
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5408447/
https://ncbi.nlm.nih.gov/pubmed/28454549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-017-0809-9
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi